Showing results (3991-4000 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 1, 2012
Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseasesTomihisa Niitsu, Masaomi Iyo, Kenji HashimotoCurrent Pharmaceutical Design|February 1, 2012
Classes of sigma2 (σ2) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activityCarmen Abate, Roberto Perrone, Francesco BerardiCurrent Pharmaceutical Design|February 1, 2012
Pharmacophore models and development of spirocyclic ligands for σ1 receptorsBernhard WunschCurrent Pharmaceutical Design|February 1, 2012
Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disordersSilvia Montoro-García, Esteban Orenes-Piñero, Francisco Marín, et al.Current Pharmaceutical Design|January 11, 2012
The ovary feels fine when paracrine and autocrine networks cooperate with gonadotropins in the regulation of folliculogenesisR Canipari, V Cellini, S CecconiCurrent Pharmaceutical Design|January 11, 2012
Early in vivo testing to assess new therapeutic interventions in CF patientsTanja GonskaCurrent Pharmaceutical Design|January 11, 2012
Stem cells in adult human ovaries: from female fertility to ovarian cancerIrma Virant-Klun, Martin Stimpfel, Thomas SkutellaCurrent Pharmaceutical Design|January 11, 2012
Application of RNA interference for the control of female reproductive functionsAlexander V SirotkinCurrent Pharmaceutical Design|January 11, 2012
Modifier gene studies to identify new therapeutic targets in cystic fibrosisRuslan DorfmanCurrent Pharmaceutical Design|January 11, 2012
New treatments for emerging cystic fibrosis pathogens other than PseudomonasValerie WatersPageof 1,008